FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
23 letters match. Newest first.
-
DrugsJing Cheong Asia Inc. dba New York Tong Ren Tang
New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.
High risk -
DrugsPhuoc Loc Tho Herbals, Inc.
FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.
High risk -
DrugsThe Platinum Healthcare LLC
The Platinum Healthcare LLC sells unapproved new drugs 'Sycosis' and 'Syphillinum' online for STIs, FDA warns.
High risk -
DrugsDesBio/Deseret Biologicals, Inc.
FDA says DesBio’s CHLA:10M, sold online for Chlamydia symptoms, is an unapproved new drug.
High risk -
DrugsRoyceDerm LLC
FDA says RoyceDerm LLC marketed Herpes Relief Cream, an unapproved new drug, for herpes symptoms on its website.
High risk -
FoodGood Stuff Cacao
FDA warns Good Stuff Cacao that disease claims make its cacao, tea, honey, goji unapproved new drugs.
Low -
DrugsPReye, LLC
FDA warned PReye, LLC that its unapproved eye drop PReye Vitamin SEE was made without sterile controls in an unclassified office.
High risk -
DrugsHerbal Dermals LLC FZ dba Gotucream
FDA warned Herbal Dermals LLC FZ dba Gotucream that its Gotucream balanitis cream is an unapproved new drug.
Low -
DrugsMantroForce
MantroForce marketed five sexual-health and prostate products as unapproved new drugs, FDA says.
High risk -
DrugsWholesale Peptide
FDA warns Wholesale Peptide that its website sells Prostamax and Gonadorelin as unapproved new drugs.
High risk -
DrugsTexinkart Inc.
Texinkart Inc. sold four Ayurvedic products online without FDA drug approval, FDA says.
High risk -
DrugsEden Health International Inc. dba Eden
FDA warned Eden Health International that its telehealth website misbrands compounded semaglutide and tirzepatide with false or misleading claims.
Low -
DrugsGSC Products, LLC
FDA told GSC Products its Sinus Plumber headache nasal spray is an unapproved new drug sold online without FDA approval.
High risk -
FoodSupersmart USA, LLC
FDA says Supersmart USA sold dietary supplements with disease-treatment claims, making them unapproved and misbranded drugs.
Low -
DrugsLovega LLC dba Pink Pony Peptides
FDA warned Pink Pony Peptides that its GLP-2 TZ, GLP-3 RT and Bacteriostatic Water are unapproved new drugs sold online.
High risk -
DrugsGram Peptides
Gram Peptides sold unapproved injectable peptide drugs and bacteriostatic water online as new drugs, FDA says.
High risk -
DrugsPrime Sciences
Prime Sciences sells injectable peptide drugs and BAC water online without FDA approval, FDA says.
High risk -
DrugsPekCura Labs
FDA warned PekCura Labs that its GLP-1-S, GLP-2-T, GLP-3-R, and bacteriostatic water products are unapproved new drugs sold online.
High risk -
DrugsWeightless Medical LLC dba WeightCare
FDA warned telehealth seller WeightCare that its website falsely presents it as the compounder of semaglutide and tirzepatide drugs.
Low -
DrugsAlan Health Technologies Inc. dba Alan
FDA warns Alan Health Technologies over website falsely labeling compounded semaglutide and tirzepatide as Alan-made.
Low -
DrugsBluefitMD
FDA warned BluefitMD that its website falsely labels compounded semaglutide and tirzepatide as its own and as FDA-approved.
Low -
DrugsDeluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics
FDA warned Deluxe IV and Aesthetics over misleading website claims for compounded semaglutide and tirzepatide, including implying FDA approval.
Low -
DrugsBeach Weekend Management LLC dba Nic and Jet Fuel
FDA told Nic and Jet Fuel its nicotine energy drinks are unapproved new drugs sold with drug-like claims.
Medium